Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei

Detalhes bibliográficos
Autor(a) principal: Loureiro, I
Data de Publicação: 2016
Outros Autores: Thoo-Lin, P, Ramos, I, Roura, M, Pruvost, A, Pemberton, I, Loukil, H, MacDougall, J, Tavares, J, Cordeiro-da-Silva, A, Graça, NA, Gaspar, L, Costa, DM
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Texto Completo: https://repositorio-aberto.up.pt/handle/10216/118203
Resumo: Current treatments for African trypanosomiasis are either toxic, costly, difficult to administer, or prone to elicit resistance. This study evaluated the activity of bisnaphthalimidopropyl (BNIP) derivatives against Trypanosoma brucei. BNIPDiaminobutane (BNIPDabut), the most active of these compounds, showed in vitro inhibition in the single-unit nanomolar range, similar to the activity in the reference drug pentamidine, and presented low toxicity and adequate metabolic stability. Additionally, using a murine model of acute infection and live imaging, a significant decrease in parasite load in BNIPDabut-treated mice was observed. However, cure was not achieved. BNIPDabut constitutes a new scaffold for antitrypanosomal drugs that deserves further consideration.
id RCAP_c252db58ff2e5ef6aa08542ea1f8d6ef
oai_identifier_str oai:repositorio-aberto.up.pt:10216/118203
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Activity of bisnaphthalimidopropyl derivatives against trypanosoma bruceiCurrent treatments for African trypanosomiasis are either toxic, costly, difficult to administer, or prone to elicit resistance. This study evaluated the activity of bisnaphthalimidopropyl (BNIP) derivatives against Trypanosoma brucei. BNIPDiaminobutane (BNIPDabut), the most active of these compounds, showed in vitro inhibition in the single-unit nanomolar range, similar to the activity in the reference drug pentamidine, and presented low toxicity and adequate metabolic stability. Additionally, using a murine model of acute infection and live imaging, a significant decrease in parasite load in BNIPDabut-treated mice was observed. However, cure was not achieved. BNIPDabut constitutes a new scaffold for antitrypanosomal drugs that deserves further consideration.American Society for Microbiology20162016-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://repositorio-aberto.up.pt/handle/10216/118203eng0066-480410.1128/AAC.02490-15Loureiro, IThoo-Lin, PRamos, IRoura, MPruvost, APemberton, ILoukil, HMacDougall, JTavares, JCordeiro-da-Silva, AGraça, NAGaspar, LCosta, DMinfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-27T18:23:32Zoai:repositorio-aberto.up.pt:10216/118203Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T22:47:05.028224Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
title Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
spellingShingle Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
Loureiro, I
title_short Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
title_full Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
title_fullStr Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
title_full_unstemmed Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
title_sort Activity of bisnaphthalimidopropyl derivatives against trypanosoma brucei
author Loureiro, I
author_facet Loureiro, I
Thoo-Lin, P
Ramos, I
Roura, M
Pruvost, A
Pemberton, I
Loukil, H
MacDougall, J
Tavares, J
Cordeiro-da-Silva, A
Graça, NA
Gaspar, L
Costa, DM
author_role author
author2 Thoo-Lin, P
Ramos, I
Roura, M
Pruvost, A
Pemberton, I
Loukil, H
MacDougall, J
Tavares, J
Cordeiro-da-Silva, A
Graça, NA
Gaspar, L
Costa, DM
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Loureiro, I
Thoo-Lin, P
Ramos, I
Roura, M
Pruvost, A
Pemberton, I
Loukil, H
MacDougall, J
Tavares, J
Cordeiro-da-Silva, A
Graça, NA
Gaspar, L
Costa, DM
description Current treatments for African trypanosomiasis are either toxic, costly, difficult to administer, or prone to elicit resistance. This study evaluated the activity of bisnaphthalimidopropyl (BNIP) derivatives against Trypanosoma brucei. BNIPDiaminobutane (BNIPDabut), the most active of these compounds, showed in vitro inhibition in the single-unit nanomolar range, similar to the activity in the reference drug pentamidine, and presented low toxicity and adequate metabolic stability. Additionally, using a murine model of acute infection and live imaging, a significant decrease in parasite load in BNIPDabut-treated mice was observed. However, cure was not achieved. BNIPDabut constitutes a new scaffold for antitrypanosomal drugs that deserves further consideration.
publishDate 2016
dc.date.none.fl_str_mv 2016
2016-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio-aberto.up.pt/handle/10216/118203
url https://repositorio-aberto.up.pt/handle/10216/118203
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0066-4804
10.1128/AAC.02490-15
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833599865217613824

Registros relacionados